Genilume
Genilume is a technology-first therapeutics company using generative AI and a systems biology-centered approach to develop innovative cancer therapies.
What We Offer
Virtual Drug Screening
Our proprietary AI platform leverages pre-clinical and clinical data to evaluate potential therapeutic indications-- for everything from biologics to small molecules, combination therapies, and more.
Clinical Trial
Insights
Our platform aims to predict therapeutic efficacy in individual patients before a clinical trial even begins-- Use it to match patients to trials and improve outcomes for everyone involved.
Precision Medicine Tools
We partner with health-tech organizations to develop specialized AI tools capable of delivering actionable patient insights and therapeutic recommendations from a secure, HIPAA-compliant platform.
Patient
Advocacy
At Genilume, we believe every individual deserves access to the latest healthcare technology and treatment options. Please contact us if you are part of a patient advocacy organization interested in partnering with us.
About Our Company
Genilume was founded by a team of scientists and engineers who sought to revolutionize precision medicine and the treatment of complex diseases like cancer. Uniting shared passions for healthcare and innovation with a commitment to excellence, Genilume was built on a foundation of strong core values and a vision for a new era of healthcare.
Subscribe
Sign up for updates below.